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Proteolytic activity and cleavage specificity of cathcpsin E were investigated in a wide range of pHs from 3.0 to 10.5 using the B chain of oxidized 
insulin as substrate. Contrary to the previous notion that cathepsin E is virtually inactive above pH 6, significant proteolytic activity eas observed 
at pH 7.4 and above. Further. cleavage specificity appeared to change significantly with pH and rather specific cleavage occurred at pH 7.4 and 
above as compared to pH 5.5 and 3.0. These results uggest that cathepsin E may function in vivo at the physiological pH with a rather estricted 
specificity. 
Cathepsin E: Gastric mucosal aspartic proteinase" Proteolytic activity; Cleavage specificity; B chain of oxidized insulin 
1. INTRODUCTION 
Human gastric cathepsin E (previously called slow 
moving protease [1], cathepsin D-like proteinase [2], 
etc.) is an aspartic proteinase present in human gastric 
mucosa. In the previous studies [2,3], we purified this 
enzyme to apparent homogeneity and investigated its 
several properties. Similar studies were also performed 
by Samloff et al. [4]. Further, the complete amino acid 
sequence of human procathepsin E has been deduced 
recently by Azuma et al. [5] from the analysis of its 
cDNA clones. On the other hand, we have reported the 
amino acid sequences of the NH_~-terminal regions of 
human gastric cathepsin E as well as procathepsin E 
[6.7] and the autocatalytic processing of procathepsin E 
into cathepsin E at pH 3.5 [7]. Cathepsin E has been 
localizaed not only to stomach mucosa, but also to 
erythrocyte membranes and several lymphoid-associat- 
ed tissues and cells including thymus, spleen, macro- 
phages, and polymorphonuclear lymphocytes [8,9]. 
However, its physiological function and the process of 
activation remain obscure. Due to its intracellular lo- 
calization in lymphoid-associated tissues and cells, it 
has been suggested to have a role in immune function 
[4,10]. It has also been suggested to be involved in the 
processing of big endothelin-I [11]. 
The optimum pH ofcathepsin E towards hemoglobin 
is 3-3.5, so its proteolytic activity and substrate speci- 
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ficity were investigated previously only at acidic pHs 
[3,12-14]. As far as cathepsin E can be active only at 
acidic pHs, its physiological roles in vivo would be 
highly restricted. Therefore, in order to shed light on the 
physiological roles of cathepsin E, it is thought o be 
very important o investigate its potential proteolytic 
activity and substrate specificity at around neutral (phy- 
siological) pHs. Furthermore, it was not always clear 
whether the enzyme preparations used in the previous 
studies were procathepsin E or cathepsin E. In fact, the 
enzyme preparation,~ we obtained previously [2,3] were 
proved tc b.,' procathepsin E [6,7]. Therefore, it is also 
thought o be important to use the activated form but 
not the proform of cathepsin E to elucidate its charac- 
teristics, especially at  the physiological pH where the 
autocatalytic activation of procathepsin E would be 
very slow or would not take place. In the present study, 
the proteolytic activity and cleavage specificity of ca- 
thepsin E were investigated in a wide range of pH from 
3.0 to 10.5 using the B chain of oxidized insulin as 
substrate. The results demonstrated for the first time 
that the enzyme possesses significant proteolytic activity 
at the physiological pH with an apparently rather 
restricted cleavage specificity. 
2, MATERIALS AND METHODS 
2.1. Materials 
Specimens of human stomachs were generously supplied by Dr. M. 
Ukai. The B chain of oxidized bovine insulin was purchased from 
Sigma. Procathepsin E was purified from the human gastric muccsa 
essentially as described previously [2,3] and the major component was 
used. Procathepsin E was activated to cathepsin E completely by 
dialyzing it against 0.05 M sodium acetate buffer, pH 1.0, containizg 
0.2 M NaCI at 4°C for 3 h and the activation mixture was applied to 
a pepstatin-Sepharose column (1.0 × 1.0 cm) equilibrated with the 
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same buffer. After washing the column with the same buffer (60 ml). 
the protein was eluted with 0.05 M Tris-HCI buffer, pH 8.0. containing 
1 M NaCI. and further purified by Mono-Qchromatography (data not 
shown). The enzyme fraction was desalted by passage through a Sep- 
hadex G-25 column and used in the present study. The purity of the 
cathepsin E sample thus prepared was confirmed by SDS-PAGE and 
the NH.,-terminal amino acid sequencing. 
2.2. Digestion of peptides and analysis of the digests 
The B chain of oxidized insulin (I00 nmol) was digested at 37°C 
• with cathepsin E (0.2 nmol, 8/ag) in 300 pl of each of the following 
buffers: 0.5 M sodium formate buffer, pH 3.0. 0.5 M sodium acetate 
buffer, pH 5.5, 0.5 M Tris-HCl buffers, pH 7.4 and 8.5, and 0.25 M 
sodium borate buffers, pH 9.5 and 10.5. Aliquots of 100 pl were 
removed at appropriate time intervals and submitted to high perform- 
ance liquid chromatography (HPLC) using a Hitachi 655A-11 system 
on a column (0.46 x 25 cm) of TSKgel ODS-120T (Tosoh Co.). The 
pcptides were eluted with a gradient of acetonitrile (0-50% in 60 rain) 
in 0.1% trifluoroacetie acid at a flow rate of 0.8 ml/min. The effluent 
was monitored by measuring the absorbance at215 nm and the pep- 
tide peak fractions were pooled and lyophilized. An aliquot of each 
peptide fraction dissolved in water was submitted to amino acid anal- 
ysis using an Applied Biosystems automated erivatizer-analyzer 
(420A/I 30A). For comparison, a synthetic hromogenic peptide sub- 
strate [15]. Lys-Pro-lte-Glu-Phe-Nph-Arg-Leu (7.2 nmol), was also 
digested by cathepsin E (0.014 nmol, 0,56 pg) at pH 7.4 for 2 h under 
similar conditions and the digest was analyzed in the same way. 
3. RESULTS 
Fig. I shows the HPLC patterns of the 3-h digest of 
the B chain of oxidized insulin at pH 3.0, 5.5 and 7.4 
as typical examples. The B chain was cleaved rapidly 
and extensively atpH 3.0 (Fig. I a), but was also hydrol- 
yzed to a considerable extent at pH 5.5 (Fig. lb) and 7.4 
(Fig. lc). As can be seen from the figure, the HPLC 
patterns were significantly different among the three pH 
values. Particularly the HPLC pattern of the digest at 
pH 7.4 appeared to be much simpler than those of the 
digest at pH 3.0 and 5.5. Upon longer incubation, hy- 
drolysis proceeded further, but the cleavage pattern at 
each pH value (data not shown) appeared to be roughly 
similar to that obtained with ti~e 3-11 digest. The HPLC 
analyses of the digests at pH 8.5, 9.5 and 10.5 showed 
that hydrolysis could also occur at these pH values 
although the rate of hydrolysis became much slower as 
the pH was raised (data not shown). The HPLC pat- 
terns of the digests at these higher pH values appeared 
to be qualitatively similar to that of the digest at pH 7.4. 
The cleavage sites and the extents of hydrolysis esti- 
mated from amino acid analysis are shown in Fig. 2 for 
the digests at pH 3.0, 5.5 and 7.4. At pH 3.0 and 5.5, 
several peptide bonds, especially FI.~-X, Tyr-X, and 
Leu-X bonds, were simultaneously cleaved to marked 
extents, whereas at pH 7.4, the Glu~3-Ala ~4 was cleaved 
fairly selectively. The extents of cleavage of this bond 
was estimated to be 22% at pH 3.0, 19% at pH 5.5, 22% 
at pH 7.4, 19% at pH 8.5, 16% at pH 9.5, and 7% at pH 
10.5. In addition, the Glu:LArg:-" bond was cleaved to 
significant extents: 6% at pH 7.4, 5% at pH 8.5, 4% at 
pH 9.5, and 3% at pH 10.5, whereas this bond was not 
hydrolysed at pH 3.0 and 5.5. Judging from the HPLC 
patterns of the digests at pH 8.5, 9.5 and 10.5 (data not 
shown), the cleavage sites appear to be similar to those 
observed at pH 7.4 although the extents of hydrolysis 
decreased as the pH was raised. By summing up the 
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Fig, 1. HPLC patterns of3-h cathepsin E digests of the B chain of oxidized insulin at pH 3.0 (a), 5.5 (b). and 7,4 (c) on a TSK gel ODS-120Tcolumn. 
The identity of each peak is shown with the residue numbers in the B chain of oxidized insulin. Peptldes obtained in yields of 1% o1' Jess are not 
shown, 
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estimated extents of h3,droiysis of individual peptide 
bonds, the total extents of hydrolysis could be calculat- 
ed. These values relative ~o that at pH 3.0 (taken as 
I00%) were 77% at pH 5.5, 17% at pH 7.4, 13% at pH 
8.5, 12% at pH 9.5, and 6% at pH 10.5. In addition, the 
enzyme was also shown to hydrolyze about 26% of the 
chromogenic substrate, Lys-Pro-Ile-Glu-Phe-Nph-Arg- 
Leu, at the Phe-Nph bond at pH 7.4 under the condi- 
tions used (data not shown). 
The proteolytic activity ofcathepsin E towards the B 
chain of oxidized insulin was completely inhibited by 
0.1 mM pepstatin at pH 3.0 and 5.5, whereas 0.1 mM 
pepstatin had no inhibitory effect when used at pH 7.4. 
Further, when cathepsin E, which had been inhibited by 
incubation with 0.1 mM pepstatin at pH 3.0 or 5.5. was 
brought o pH 7.4, the enzyme restored full activity and 
essentially the same HPLC pattern as that obtained 
without pepstatin was obtained. Neither ATP (6 mM) 
nor any of the following protease inhibitors: 0.1 mM 
diisopropylfluorophosphate, 1 mM phenylmethanesul- 
fonyl fluoride, I0 mM o-phenanthroline, 0.05 mM di- 
protin A. 0.1 mM leupeptin. 0.I mM antipain, 0.1 mM 
E-64. and 0.1 mM amastatin, affected the hydrolysis at 
pH 7.4. 
4. DISCUSSION 
Gastric cathepsin E is an aspartic proteinase opti- 
mally active at pH around 3 and has been thought to 
be devoid of proteolytic activity at neutral pH values. 
Indeed, it was reported to have rather low activity at pH 
5 and practically no activity at pH above 6 towards 
hemoglobin as substrate [2,16]. In the present study, 
however, human gastric cathepsin E was found to pos- 
sess rather high activity at pH 5.5 and still significant 
activity at pH 7.4 (and above) towards the B chain of 
oxidized insulin. Reduced and carboxymethylated ribo- 
nuclease A and several other peptides were also shown 
to be hydrolyzed to significant extents by cathepsin E 
at pH 7.4 analyzed in the same manner (Athauda, 
$.B.P. et al., to be published). Further, the activity at 
pH 7.4 towards the B chain of oxidized insulin was not 
inhibited by any of  the serine, cysteine, and metallo- 
proteinase inhibitors tested, indicating that this activity 
is due to cathepsin E itself and not to a contaminating 
proteinase(s). Thus, gastric cathepsin E was shown for 
the first time to be significantly active towards certain 
polypeptide substrates at neutral to slightly alkaline pH 
values. This finding suggests that cathepsin E may func- 
tion in vivo in a wider physiological pH range than was 
hitherto considered. 
Previously, Thomas et al. [I 7] reported that cathep- 
sins E from human gastric mucosa and red blood cells 
were virtually inactive at pH 5.8 towards ynthetic hro- 
mogenic peptide substrates and [3H]casein, but that the 
activity was expressed at pH values up to about 6.6 in 
the presence of ATP (6.25 mM): due to stabilization of 
the enzyme by ATP. In the present study, however, our 
cathepsin E preparation hydrolyzed one of the same 
synthetic peptide substrates rather rapidly at pH 7.4 at 
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Fig. 2. Yields of peptides produced from the B cl~;Jin of oxidized insulin by cathepsin E and the sites of cleavage at pH 3.0 (;0. 5.5 {b), and 7.4 
(c). Bars indicate peptide fragnaents produced, and the number in each bar shows the percent yield of the peptide. Arrowheads indic~lte the cleavage 
sites, and the nttmber under each ~trrowhead shows the estimated extent of cleavage in percent of lhe peptide bond. Large. medium, and small 
arrowheads indicate major, secondary, and minor cleavage sites, respectively. 
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the Phe-Nph bond in the absence of ATP. Further, 
ATP (6.25 raM) had no effect on the rate of hydrolysis 
of the B chain of  oxidized insulin at pH 7.4. The reason 
for this discrepancy is not certain at present. It is now 
known that human gastric cathepsin E purified under 
the conditions at pH above 7 is actually procathepsin 
E, which can be autocatalytically activated to cathepsin 
E under acidic conditions [6,7]. Therefore, the enzyme 
preparation which displayed some activity at pH 6.6 
only in the presence of ATP might possibly be procat- 
hepsin E rather than cathepsin E. 
The rather selective cleavage of the Glul3-Ala 14 bond 
in the B chain of oxidized insulin at pH 7.4 suggests that 
cathepsin E may be involved in limited proteolysis of 
certain proteins and/or peptides under neutral (physio- 
logical) conditions. The reason for the change in cleav- 
age specificity with pH is not very clear, but the differ- 
ence in ionization state in the enzyme active site region 
and/or the substrate molecule would be primarily re- 
sponsible for this change. The enzyme appears to prefer 
the ionized form to be unionized form of glutamie acid 
residue in the GIu-X bonds to be cleaved. Interestingly, 
the enzyme was not inhibited by pepstatin at pH 7.4, 
although it was strongly inhibited by pepstatin at pH 3.0 
and 5.5. This indicates that the enzyme has little affinity 
to pepstatin at pH 7.4. Therefore, the enzyme is no more 
a pepstatin-sensitive proteinase at neutral pH. 
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